Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 4, 2010, Pages 323-331

  Lin, Cheng Chih ^a   Liu, Te Chu ^a,b   Kuo, Chen Feng ^a   Liu, Chang Pan ^a,c   Lee, Chun Ming ^a,c,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter baumannii; Colistin; Drug resistance; Inhaled; Multiple; Nosocomial pneumonia; Polymyxin

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN; COLISTIN; MONOBACTAM; NEOMYCIN; PENICILLIN DERIVATIVE; QUINOLONE; ANTIINFECTIVE AGENT;

ABSENCE OF SIDE EFFECTS; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; RETROSPECTIVE STUDY; SCORING SYSTEM; TAIWAN; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTIONS; CRITICAL ILLNESS; DRUG EFFECTS; HOSPITAL; INHALATIONAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COLISTIN; CRITICAL ILLNESS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME;

EID: 77955316671     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60050-3     Document Type: Article

References (31)

1. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar AE, García-Garmendia JL, Bernabeu-WittelI M, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003, 36:1111-1118.
2. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME Colistin treatment in patients with ICU-acquired in fections caused by multi-resistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005, 11:15-21.
3. Beringer P The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 2001, 7:434-440.
4. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005, 9:R53-R59.
5. Kwa AL, Loh C, Low JG, Kurup A, Tam VH, Kwa ALH, et al. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2005, 41:754-757.
6. Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, et al. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med 2008, 102:407-412.
7. Linden PK, Paterson DL, Linden PK, Paterson DL Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin Infect Dis 2006, 43(Suppl 2):S89-S94.
8. Wayne P. Performance standards for antimicrobial susceptibility testing. Document M100-S17: Clinical Laboratory Standards Institute, 2007.
9. Munoz-Price LS, Weinstein RA Acinetobacter infection. N Engl J Med 2008, 358:1271-1281.
10. Karageorgopoulos DE, Falagas ME Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8:751-762.
11. Owen RJ, Li J, Nation RL, Spelman D, Owen RJ, Li J, et al. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2007, 59:473-477.
12. Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 2006, 4:138-146.
13. Plachouras D, Giamarellos-Bourboulis EJ, Kentepozidis N, Baziaka F, Karagianni V, Giamarellou H, et al. In vitro post-antibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2007, 57:419-422.
14. Rios FG, Luna CM, Maskin B, Saenz Valiente A, Lloria M, Gando S, et al. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms. Eur Respir J 2007, 30:307-313.
15. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999, 28:1008-1011.
16. Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005, 49:3136-3146.
17. Kallel H, Hergafi L, Bahloul M, Hakim A, Dammak H, Chelly H, et al. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med 2007, 33:1162-1167.
18. Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W, Chelly H, et al. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents 2006, 28:366-369.
19. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, et al. Intravenous colistin in the treatment of sepsis from multi-resistant Gram-negative bacilli in critically ill patients. Crit Care 2003, 7:R78-R83.
20. Falagas ME, Rizos M, Bliziotis IA, Rellos K, Kasiakou SK, Michalopoulos A Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 2005, 5:1.
21. Falagas ME, Kasiakou SK Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006, 10:R27.
22. De Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000, 26:915-921.
23. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
24. Ratjen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 2006, 57:306-311.
25. Horianopoulou M, Lambropoulos S, Papafragas E, Falagas ME Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis. J Chemother 2005, 17:536-538.
26. Pereira GH, Muller PR, Levin AS Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B. Diagn Microbiol Infect Dis 2007, 58:235-240.
27. Hamer DH Treatment of nosocomial pneumonia and tracheo-bronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000, 162:328-330.
28. Palmer LB, Smaldone GC, Chen JJ, Baram D, Duan T, Monteforte M, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008, 36:2008-2013.
29. Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A Inhaled colistin as monotherapy for multidrug-resistant gram(-) nosocomial pneumonia: a case series. Respir Med 2009, 103:707-713.
30. Hawley JS, Murray CK, Jorgensen JH, Hawley JS, Murray CK, Jorgensen JH Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 2008, 52:351-352.
31. Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaioannou V, Ntani G, et al. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med 2008, 36:807-811.